康莱特在晚期肺癌缓和医疗中的作用

Abstract
Figure/Table
References (16)
Related Citation (2)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Kanglaite Injection on physical ability,cancer pain,traditional Chinese medicine symptoms,mental symptom of patients with advanced lung cancer,to evaluate its role in palliative care of advanced lung cancer.Methods 101 patients with advanced lung cancer were selected from August 2014 to May 2017 in Zhongguancun Hospital,which were divided into the observation group (49 cases)and the control group (52 cases)according to different treatment methods.Patients in control group were given supportive treatments only,and the observation group was given Kanglaite Injection for two cycles on the basis of the control group.The therapeutic effects of the two groups were compared.Results The score of Karnofsky and pain score in the observation group was better than that in the control group,with significant difference (P＜0.05).After treatment,the scores of traditional Chinese medicine symptoms,scores of anxiety and depression in the observation group was lower than that in the control group,with significant difference(P＜0.05).There was no significant difference in the incidence rate of adverse reactions between the two groups(P＞0.05).Conclusion Kanglaite Injection plays an important role in palliative care,and it can improve life quality of advanced lung patient.

Key words： Kanglaite Injection Advanced lung cancer Palliative care

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	RONG Xiu-mei
	WANG Su
	LI Dong-yun

Cite this article:

RONG Xiu-mei,WANG Su,LI Dong-yun. Effect of Kanglaite on palliative care in patients with advanced lung cancer[J]. 中国当代医药, 2017, 24(27): 86-88.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I27/86

[1]	Fernández-López C，Expósito-Hernández J，Arrebola-Moreno JP，et al.Trends in phase Ⅲ randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer[J].Cancer Med，2016，5（9）：2190-2197.
[2]	YangSC，LaiWW，Hsiue TR，et al.Health-related quality of life after first-line anti-cancer treatments for advanced nonsmall cell lung cancer in Szu-Chun Yang[J].Qual Life Res，2016，25（6）：1441-1449.
[3]	Guijarro-Mumoz I，Roarty EB，Heymach JV.Bevacizumab beyond disease progression for advanced non-small cell lung cancer：does persistence have its rewards?[J].Cancer，2016，122：1047-1049.
[4]	葛洋，安广宇.肿瘤内科临床教学中的伦理学教育探讨医学模式的转换[J].中国病案，2017，18（5）：86-89.
[5]	王雨婷，董碧蓉.缓和医疗概述[J].现代临床医学，2016，42（2）：157-160.
[6]	King JD，Eickhoff J，Traynor A，et al.Integrated onco-palliative care associated with prolonged survival compared to standard care for patients with advanced lung cancer：a retrospective review[J].J Pain Symptom Manage，2016，51（6）：1027-1032.
[7]	秦银忠.康莱特配合放疗对非小细胞肺癌的疗效及患者免疫功能的影响[J].实用癌症杂志，2016，31（4）：578-580.
[8]	陈维，魏涛.康莱特注射液联合吉西他滨顺铂方案治疗晚期非小细胞肺癌的临床疗效及对患者免疫功能的影响[J].中国肿瘤临床与康复，2016，23（7）：814-817.
[9]	马宣，周玮.康莱特注射液对晚期非小细胞肺癌患者免疫功能及生活质量的影响[J].中药药理与临床，2015，31（2）：184-185.
[10]	李骁，王文萍.康莱特注射液治疗中晚期非小细胞肺癌有效性及安全性Meta分析[J].辽宁中医药大学学报，2017，19（3）：170-173.
[11]	安青.补精解毒方治疗中晚期非小细胞肺癌临床疗效分析[J].辽宁中医药大学学报，2013，13（7）：80-82.
[12]	宴四平，苏德森.不饱和脂肪酸抗肿瘤作用研究进展[J].辽宁药物与临床，2013，3（1）：36-39.
[13]	许志文，谢翔，黄立峰，等.高温雾化吸入顺铂联合康莱特治疗晚期肺癌的临床研究[J].中国现代医生，2016，54（28）：87-90.
[14]	张萌.康莱特注射液对晚期癌症患者生存质量影响的临床分析[J].系统医学，2016，1（2）：60-62.
[15]	何六涛，吴晓虞，余旭舟.康莱特注射液用于改善晚期肺癌患者临床效果及生活质量疗效分析[J].现代实用医学，2017，29（3）：329-330.
[16]	朱莺，吴厉峰，施肖红.康莱特注射液对晚期非小细胞肺癌情绪和睡眠的影响[J].新中医，2014，42（12）：164-165.